Cargando…
An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia
BACKGROUND: Therapeutic cancer vaccines are an attractive approach for treating malignant tumours, and successful tumour eradication depends primarily on controlling tumour immunosuppression status as well as heterogeneity of tumour cells driven by epigenetic alterations. METHODS: Peptide-loaded den...
Autores principales: | Shin, A-Ri, Lee, Sang-Eun, Choi, Haeyoun, Sohn, Hyun-Jung, Cho, Hyun-Il, Kim, Tai-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492404/ https://www.ncbi.nlm.nih.gov/pubmed/32595211 http://dx.doi.org/10.1038/s41416-020-0955-y |
Ejemplares similares
-
Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970) -
Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019) -
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
por: Grove, Carolyn S., et al.
Publicado: (2014) -
Single cell analysis of clonal architecture in acute myeloid leukaemia
por: Potter, Nicola, et al.
Publicado: (2018) -
A Kinetic Study On Murine Myeloid Leukaemia
por: Tanaka, T., et al.
Publicado: (1970)